News
6h
Zacks Investment Research on MSNAll You Need to Know About Exponent (EXPO) Rating Upgrade to Buy
Investors might want to bet on Exponent (EXPO), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of ...
Treatt said it agreed to a 156.6 million pound ($211.6 million) takeover from Natara Global, a company controlled by funds managed by Exponent Private Equity. The U.K. supplier of flavor and fragrance ...
Exponent’s revenue has grown at a CAGR of 6% while EBITDA has at 8%. This has been driven by its fantastic business model and industry tailwinds. Exponent provides highly complex consulting ...
Scientific consulting firm Exponent (NASDAQ:EXPO) will be reporting earnings this Thursday afternoon. Here’s what to expect.
Zooming In On Exponent (EXPO) Exponent’s shares are not very volatile and have only had 3 moves greater than 5% over the last year.
Exponent soars on impressive Q1 FY24 results, with sales surging 3.3% YoY to $144.933M, outperforming estimates. Engineering and scientific services dominate revenue, comprising 84% of Q1 earnings ...
Former Jewish Exponent Director of Business Operations Cheryl Lutts was sentenced on July 25 to 20 months in federal prison for embezzling about $1.7 million from the Exponent and her subsequent ...
Former Jewish Exponent Director of Business Operations Cheryl Lutts pleaded guilty in federal court on June 28 to 24 counts of wire and mail fraud involving both the Exponent and subsequent employer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results